According to Alaunos Therapeutics's latest financial reports the company's current revenue (TTM) is $0 M. In 2022 the company made a revenue of $2.92 M an increase over the years 2021 revenue that were of $0.39 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0 M | -99.83% |
2022 | $2.92 M | 634.17% |
2021 | $0.39 M | |
2020 | N/A | |
2019 | N/A | -100% |
2018 | $0.14 M | -97.71% |
2017 | $6.38 M | -6.88% |
2016 | $6.86 M | 58.38% |
2015 | $4.33 M | 215.51% |
2014 | $1.37 M | 71.63% |
2013 | $0.8 M | 0% |
2012 | $0.8 M | 19.94% |
2011 | $0.66 M | |
2010 | N/A | |
2009 | N/A | |
2002 | $0 M | 48.9% |
2001 | $0 M |